COVID-19 DISRUPTION IN CHINA BEYOND APRIL WILL MAKE INDIAN PHARMACEUTICALS WORRIED

Highlights:

• India imports 70% of API from China
• Till April 2020 Indian pharma-sector stocked with API
• Beyond April 2020, it will be a worrisome state for India

Indian Pharmaceutical companies will have to bear the cost of China’s COVID-19 disruption.

In the global economy, China has a vital role to play. With corona virus almost breaking China’s back, the rest of t....